MARK JEROME PYKETT

CIK 1278271 · CEO · last filed 2014-03-11

MARK JEROME PYKETT is a CEO who has filed 20 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing shows the insider sold $235.2K of NAVB on Mar 11, 2014. Across all open-market trades the lifetime net is −$192.5K, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

20

Lifetime Open-Market Net

-$192.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted CEO 283,774 $0.00 $28 -$204.9K 10 2014-03-11
NAVIDEA BIOPHARMACEUTICALS, INC. (NEOP) Delisted Pres. & CEO 4,400 $11.4K 1 2011-08-23
Savara Inc (ANX) Delisted Director 8,000 $1.0K 5 2010-07-01
ALSERES PHARMACEUTICALS INC /DE (ALSE) Delisted President and COO 6,777 $0 2 2009-01-16
ALSERES PHARMACEUTICALS INC /DE (BLSI) Delisted President & COO $0 1 2007-06-08

Recent Filings

20 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2014-03-11 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Sell (S) −120,000 -$235.2K EDGAR
2014-01-31 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Grant (A) $0 EDGAR
2013-11-08 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Buy (P) +10,900 $14.7K EDGAR
2013-03-27 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Mixed +116,698 -$184.2K EDGAR
2013-03-27 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Disp (D) −34,074 -$104.9K EDGAR
2013-03-18 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Buy (P) +1,850 $5.0K EDGAR
2013-03-15 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Mixed +81,764 -$136.6K EDGAR
2013-02-19 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Mixed −35,000 -$107.8K EDGAR
2012-09-14 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Buy (P) +4,000 $10.6K EDGAR
2012-02-22 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Grant (A) +300,000 $0 EDGAR
Showing 110 of 20
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.